A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.

Affiliation

Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, OX3 7FZ, UK. [Email]

Abstract

Despite much progress in cancer research, its incidence and mortality continue to rise. A robust biomarker that would predict tumor behavior is highly desirable and could improve patient treatment and prognosis.

Keywords

Gene signature,Hepatocellular carcinoma,Hypoxia,Pan-cancer,T cells,Tumor-infiltrating lymphocytes,

OUR Recent Articles